ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1216

Evidence of a Tendency for Localized Recurrence of Arthritis in Rheumatoid Arthritis Patients

Sascha Heckert1, Sytske Anne Bergstra1, Xanthe Matthijssen1, Yvonne Goekoop-Ruiterman2, Faouzia Fodili3, Saskia ten Wolde4, Cornelia F. Allaart1 and Tom WJ Huizinga1, 1Leiden University Medical Center, Leiden, Netherlands, 2HagaZiekenhuis, The Hague, Netherlands, 3Stichting ReumaZorg ZWN, Roosendaal, Netherlands, 4Spaarne Gasthuis, Haarlem, Netherlands

Meeting: ACR Convergence 2021

Keywords: Inflammation, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Prediction, Biomarkers, & Treatment Response (1196–1222)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Local inflammation may cause synovial fibroblasts to become sensitized, resulting in higher susceptibility to arthritis. Longitudinal assessment of joint involvement in rheumatoid arthritis (RA) might show if clinical arthritis tends to recur in the same joints.

Methods: Data from the BeSt study were used, a treat-to-target (disease activity score ≤2.4) study in 508 newly diagnosed RA (ACR 1987 criteria) patients. During 10 years, three-monthly 68-joint assessments (swelling yes/no and Ritchie Articular Index) were done by trained nurses.

We analyzed the association between local joint swelling at baseline and later swelling of the same joint using a multilevel mixed-effects logistic regression model, adjusted for joint location and for timepoint, with joints clustered within patients. A sensitivity analysis was done for the 25% joints that were most often swollen in the study population (MCP 1-3, PIP 2-3, wrists and MTP 2-4).A permutation test was performed to assess if over time joint swelling was better predicted (indicated by a p-value of < 0.05) by baseline swelling of the same joint than by baseline swelling of randomly selected other joints. This was repeated for the joints that were most often swollen.

The association between baseline joint swelling and the number of joint swelling episodes during follow-up was evaluated using a multilevel Poisson regression model, adjusted for joint location and follow-up duration, clustered within patients.

All models were repeated to account for missing data in two ways. First, all missing joint evaluations until end of follow-up were regarded as not swollen. Second, last observation was carried forward for one missing time point if the joint evaluation (swelling yes/no) at the time point before a missing evaluation was the same as at a subsequent time point after the missing evaluation.

Results: At baseline, 8,137/34,423 (24%) assessed joints were scored as swollen. Swelling recurred at least once in 46% of the joints with baseline swelling. Baseline swelling was significantly associated with swelling in the same joint during follow-up (odds ratio 2.37, 95% CI 2.30-2.43, p< 0.001). This association also was found in the 25% most swollen joints (OR 2.11, 95% CI 2.03 to 2.19, p< 0.001). Local joint swelling (in all joints and in the most susceptible joints) was better predicted by baseline swelling of that particular joint than by baseline swelling of other joints (p< 0.001). Baseline joint swelling was also predictive for the number of joint swelling episodes in that joint during follow-up (incidence rate ratio 1.48, 95% CI 1.37 to 1.59, p< 0.001). When accounted for missing data, using the two different methods described before, all models showed similar results.

Conclusion: In RA patients treated to target DAS ≤ 2.4, joint swelling tends to recur locally in the joints swollen at presentation. This suggests that local factors influence the manifestation of joint inflammation over time and might indicate that joints that are swollen at disease onset may require additional monitoring and treatment.


Disclosures: S. Heckert, None; S. Bergstra, Pfizer, 5; X. Matthijssen, None; Y. Goekoop-Ruiterman, None; F. Fodili, None; S. ten Wolde, None; C. Allaart, Dutch College of Health Insurances, 5, Schering-Plough BV, 5, Centocor Inc., 5, Eli Lilly, 5; T. Huizinga, None.

To cite this abstract in AMA style:

Heckert S, Bergstra S, Matthijssen X, Goekoop-Ruiterman Y, Fodili F, ten Wolde S, Allaart C, Huizinga T. Evidence of a Tendency for Localized Recurrence of Arthritis in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/evidence-of-a-tendency-for-localized-recurrence-of-arthritis-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-of-a-tendency-for-localized-recurrence-of-arthritis-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology